Surgery – Controlled release therapeutic device or system – Implanted dynamic device or system
Patent
1997-04-30
2000-03-28
McDermott, Corrine
Surgery
Controlled release therapeutic device or system
Implanted dynamic device or system
604503, 604 93, A61M 1100, A61M 922
Patent
active
060425792
ABSTRACT:
Techniques for infusing nerve growth factors into the brain to treat neurodegenerative disorders by means of an implantable pump and catheter. A sensor is used to detect an attribute of the nervous system which reflects the degeneration of the nerve cells. A microprocessor algorithm analyzes the output from the sensor in order to regulate the amount of growth factor delivered to the brain.
REFERENCES:
patent: 4003379 (1977-01-01), Ellinwood, Jr.
patent: 4146029 (1979-03-01), Ellinwood, Jr.
patent: 4692147 (1987-09-01), Duggan
patent: 5011472 (1991-04-01), Aebischer et al.
patent: 5025807 (1991-06-01), Zabara
patent: 5106627 (1992-04-01), Aebischer et al.
patent: 5293879 (1994-03-01), Vonk et al.
patent: 5462525 (1995-10-01), Srisathapat et al.
patent: 5474547 (1995-12-01), Aebischer et al.
patent: 5558640 (1996-09-01), Pfeiler et al.
patent: 5639275 (1997-06-01), Baetge et al.
patent: 5643207 (1997-07-01), Rise
patent: 5711316 (1998-01-01), Elsberry et al.
patent: 5735814 (1998-04-01), Elsberry et al.
patent: 5792110 (1998-08-01), Cunningham
Alexander et al., "Basal ganglia thalamocortical circuits: Parallel substrates for motor, oculomotor, `prefrontal` and `limbic` functions," Progress in Brain Research, vol. 85, pp. 119-146 (1990).
Appel, "Exitotixic Neuronal Cell Death in Amyotrophic Lateral Sclerosis", TINS, vol. 16, No. 1 (1993).
Appel, "A Unifying Hypothesis for the Cause of Amyotrophic Lateral Sclerosis, Parkinsonism, and Alzheimer Disease", Annals of Neurology, ovl. 10: No. 6: 449-505 (Dec. 1981).
Couratier et al., "Cell Culture Evidence for Neuronal Degeration in Amyotrophic Lateral Sclerosis Being Linked to Glutamate AMPA/Kainate Receptors", The Lancet, 341, pp. 265-268 (1993).
Graham, et al., Injection of Excitatory Amino Acid Antagonists Into the Medial Pallidal Segment of a 1-Methyl-4-Phenyl-1,2,3,6-tetrahydropyridine (MPTP) Treated Primate Reverses Motor Symptoms of Parkinsonism, Life Sciences, vol. 47, pp. PL-91-PL-97 (1990).
Kroll, et al., "Increasing Volume of Distribution to the Brain with Interstitial Infusion: Dose, Rather Than Convection, Might Be the Important Factor", Neurosurgery, vol. 38, No. 4, pp. 746-754 (1996).
Osorio et al., "A Method for Accurate Automated Real-Time Seizure Detection," Epilepsia, vol. 36, Supplement 4 (1995).
Rothman et al., "Excitotoxicity and the NMDA receptor" Trends Neuroscience 10, pp. 229-302 (1990).
Schiff et al., "Controlling chaos in the brain," Nature vol. 370, pp. 615-620 (1994).
van Horne et al., "Multichannel semiconductor-based electrodes for in vivo electrochemical and electrophysiological studies in rat CNS", Neuroscience Letters 120, pp. 249-252 (1990).
Friedman, W.J. et al., Differential actions of neurotrophins in the locus coeruleus and basal forebrain, Experimental Neurology 119, pp. 72-78 (1993).
Hagg, T. and S. Varon, Ciliary neurotrophic factor prevents deneration of adult rat substantia nigra dopaminergic neurons in vivo, Proceedings National Academy of Science, USA 90 pp. 6315-6319 (1993).
Henderson, C.E., et al., Neurotrophins promote motor neuron servival and are present in embryonic limb bud, Nature 363 pp. 266-270 (1993).
Knusel, B., et al., Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain, Journal of Neuroscience 12(11) pp. 4391-4402 (1992).
Koliatsos, V.E. et al., Highly selective effects of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 on intact and injured basal forebrain magnocllular neurons, Journal of Comparative Neurology343 pp. 247-262 (1994).
Lapchak, P. A., Nerve growth factor pharmacology: Application to the treatment of cholinergic neurodeneration in Alzheimer's disease, Experimental Neurology 124 pp. 16-20 (1993).
Lapchak, P.A., et al., Biology of glial cell line-derived neurotrophic factor (GDNF): Implications for the use of GDNF to treat Parkinson's disease, Neurodegeneration 5 pp. 197-205 (1996).
Olson, L. et al., Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease, Archives of Neurology 48 pp. 373-381 (1991).
Pelleymounter, M. A. and Cullen M. J., The effects of intraseptal brain-derived neurotrophic factor on cognition in rats with MS/DB lesions, Annals New York Academy of Sciences 679 pp. 299-305 (1993).
Seiger, et al., Intracranial infusion of purified nerve growth factor to an Alzheimer patient: The first attempt of a possible future treatment strategy, Behavioral Brain Research 57 (2) pp. 255-261 (1993).
Sendtner, M. et al., Actions of CNTF and neurotrophins on degenerating motoneurons: preclinical studies and clinical implications, Journal of Neurological Sciences 124 (Supp) pp. 77-83 (1994).
Tomac, A., et al., Protection and repair of the nigrostriatal dopaminergic system by DGNF in vivio, Nature 373 pp. 335-346 (1995).
Widmer, H. R. et al., BDNF protection of basal forebrain cholinergic neurons after axotomy: complete protection of p75NGFR-positive cells, Neuroreport 4 pp. 363-366 (1993).
Zhang, Y., et al., Basic FGF, NGF, and IGFs protect hippocampal and cortical neurons agains iron-induced deneration, Journal of Cerebral Blood Flow and Metabolism 13 pp. 378-388 (1993).
Stewart, S. S., et al., Trophic factors in neurologic disease, Annual in Medicine 39 pp. 193-201 (1988).
Elsberry Dennis D.
Rise Mark T.
Hayes Michael J.
McDermott Corrine
Medtronic Inc.
LandOfFree
Techniques for treating neurodegenerative disorders by infusion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Techniques for treating neurodegenerative disorders by infusion , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Techniques for treating neurodegenerative disorders by infusion will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1322025